Old Web
English
Sign In
Acemap
>
authorDetail
>
Yu Komiya
Yu Komiya
Biology
Cancer research
Cancer
Metastasis
Tumor progression
5
Papers
35
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TAS4464, a highly potent and selective inhibitor of NEDD8 activating enzyme, suppresses neddylation and shows antitumor activity in diverse cancer models
2019
Molecular Cancer Therapeutics
Chihoko Yoshimura
Hiromi Muraoka
Hiroaki Ochiiwa
Shingo Tsuji
Akihiro Hashimoto
Hiromi Kazuno
Fumio Nakagawa
Yu Komiya
Satoshi Suzuki
Toru Takenaka
Masafumi Kumazaki
Naoya Fujita
Takashi Mizutani
Shuichi Ohkubo
Show All
Source
Cite
Save
Citations (23)
Abstract B136: NEDD8-activating enzyme inhibitor TAS4464 inhibits tumor growth in endometrial cancer mouse model accompanied by DNA damage response
2018
Molecular Cancer Therapeutics
Yu Komiya
Chihoko Yoshimura
Hiromi Muraoka
Shuichi Ohkubo
Fumio Nakagawa
Hiroaki Ochiiwa
Hiroshi Sootome
Takashi Mizutani
Kenichi Matsuo
Teruhiro Utsugi
Yoshikazu Iwasawa
Show All
Source
Cite
Save
Citations (0)
The Rho guanine nucleotide exchange factor ARHGEF5 promotes tumor malignancy via epithelial–mesenchymal transition
2016
Yu Komiya
Yasuhito Onodera
Miho Kuroiwa
Suguru Nomimura
Kubo Y
Jin-Min Nam
Kentaro Kajiwara
Shigeyuki Nada
Chitose Oneyama
Hisataka Sabe
Masato Okada
Show All
Source
Cite
Save
Citations (12)
The activation mechanism of ARHGEF5 during tumor progression がん進展におけるARHGEF5活性化機構の解析
2015
The Molecular Biology Society of Japan
Jun jie Choo
Yu Komiya
Suguru Nomimura
Masato Okada
Show All
Source
Cite
Save
Citations (0)
Arhgef5 is upregulated during TGF-β-induced epithelial-mesenchymal transition and promotes tumor progression
2015
The Molecular Biology Society of Japan
Yu Komiya
Suguru Nomimura
Yasuhito Onodera
Miho Kuroiwa
Shigeyuki Nada
Masato Okada
Show All
Source
Cite
Save
Citations (0)
1